EGFR and lung cancer: Park et al. [161] designed sgRNAs targeting the endogenous EGFR genomic region flanking the exon encoding T790 to generate a PC9 lung cancer cell line harboring EGFR T790M, investigating the molecular mechanisms of tyrosine kinase inhibitors resistance.